Electromed vs Tela Bio
Electromed and Tela Bio are similar in size: $73.8m and $80.3m of revenue in their latest fiscal years. Tela Bio grew faster (15.8% against 15.3%). Electromed kept more of each dollar of sales as profit: a net margin of 15.3% against -48.4%.
| Latest fiscal year | ElectromedELMD, 2026 | Tela BioTELA, 2025 |
|---|---|---|
| Revenue | $73.8m | $80.3m |
| Revenue growth | 15.3% | 15.8% |
| Net income | $11.3m | −$38.8m |
| Operating margin | — | -42.0% |
| Net margin | 15.3% | -48.4% |
| Return on equity | 23.3% | — |
| Free cash flow | $8.4m | −$28.7m |
| Cash | $20.4m | $50.8m |
| Total debt | $0 | $55.7m |
| Debt to equity | — | 881.6% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $3.9m | — |
| Employees | 197 | 150 |
| Market value | $224m | $35.2m |
| Price vs our value range | Below our value range | — |
| Moat score | 69 (Moderate) | 34 (Weak) |
| Insider trades, 12 months | 0 buys, 9 sales | 7 buys, 0 sales |